Atea Pharmaceuticals, Inc.AVIRNASDAQ
Loading
Income Quality Over TimeStrong
Percentile Rank57
3Y CAGR-7.2%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
-7.2%/yr
vs +4.6%/yr prior
Acceleration
-11.8pp
Decelerating
Percentile
P57
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
20250.83+3.6%
20240.80+28.1%
20230.63-39.8%
20221.04+245.4%
2021-0.72+97.4%
2020-27.11-3068.7%
20190.91+4.7%
20180.87-